BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

TruTag Technologies Debuts New Portable Authentication Reader at the Seventh Global Forum on Pharmaceutical AntiCounterfeiting and Diversion in Washington, DC


11/29/2012 10:52:37 AM

HONOLULU, Nov. 28, 2012 /PRNewswire/ -- TruTag Technologies today announced their participation in the Seventh Global Forum on Pharmaceutical AntiCounterfeiting and Diversion in Washington, DC, taking place November 27-29, 2012 at the Omni Shoreham Hotel. This East Coast conference is one of the largest global forums dedicated to the reduction and elimination of counterfeit and diverted medicine, and is held in proximity to an area with one of the greatest concentrations of pharmaceutical companies in the world.

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/59342-trutag-technologies-debuts-new-portable-authentication-reader

(Photo: http://photos.prnewswire.com/prnh/20121128/MM18946 )

The venue is an ideal opportunity for TruTag to introduce its revolutionary technology before an audience that brings together all constituents, including patient groups, government regulators, healthcare personnel, pharmaceutical manufacturers, and anti-counterfeiting solution providers. In addition, TruTag will debut and demonstrate its new portable optical reader, which can authenticate solid oral dose medicines marked with the TruTag® microtag solution. "We look forward to demonstrating our ground-breaking drug authentication solution to such an experienced and knowledgeable audience, as well as participating in the seminars, workshops, and other discussions at this significant event," said TruTag President Kent Mansfield.

TruTag's "covert, edible bar codes" provide drug makers with a product security and tracking solution at the dosage level, rather than on packaging, so that manufacturers can authenticate medicine directly on a pill with the ability to confirm the product strength, batch number, site of manufacture and expiration date, among other product information.

In late 2011, the U.S. Food and Drug Administration issued final guidance to the drug industry for the use of physical-chemical identifiers (PCIDs) as on dose authentication measures like TruTag's solution in drug products. This latest FDA guidance provides a strong framework for pharmaceutical manufacturers to begin implementing PCIDs in solid oral dosage form drug products. "With the PCID Guidance and other actions, the FDA has demonstrated that addressing the problem of counterfeit and diverted drugs is one of its highest priorities," said TruTag Chief Operating Officer Peter Wong.

TruTag's high-purity silica microtags are inert and can be associated with a variety of product information, similar to a traditional bar code. Further, silica (silicon dioxide) has long been used as an excipient in food and medicine, and is well-suited for the PCID Guidance because it has been affirmed as "generally recognized as safe," or GRAS, by the FDA. TruTag's novel drug authentication technology won the 2010 North American Pharmaceutical and Biotechnology Innovation of the Year award presented by Frost & Sullivan.

About TruTag Technologies:
TruTag Technologies has developed a covert, low-cost, heat-resistant, and edible silica microtag (called TruTag®) that serves as an edible bar code and can be incorporated into solid oral dose medications as well as other materials and products. This on dose technology platform can be used to help prevent counterfeiting, improve tracking and authentication, add efficiency to clinical trials administration, provide informatics for product and component tracking through the supply chain, and assure product quality. The unique physical properties of TruTag® microtags provide a vast library of available unique codes, which allow for tracking of high volume, high value items at product or even batch levels. This serialized business information tool can be used in a variety of markets with high-value items, including, but not limited to pharmaceuticals, nutritional supplements, food, electronics and medical devices. Learn more at www.trutags.com

TRUTAG is a registered trademark of TruTag Technologies, Inc.

©2012 TruTag Technologies, Inc. All rights reserved.

Contact:
Paula Page
(650)279-3881
paula@paulapagepr.com

SOURCE TruTag Technologies



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES